灭活COVID-19疫苗接种不影响女性体外受精结局
该回顾性队列研究纳入240例接种灭活COVID-19疫苗(CoronaVac或国药)和1343例未接种的不孕女性,比较卵巢刺激、胚胎发育及妊娠率。调整混杂因素后,接种组持续妊娠率36.3% vs 未接种组40.7%(P=0.199),无显著差异;倾向性评分匹配后各项妊娠率亦无显著差异。作者认为接种对IVF结局无不利影响,推荐女性在IVF治疗前接种COVID-19疫苗。
要点
- 接种组持续妊娠率36.3% vs 未接种组40.7%(P=0.199),无显著差异
- 匹配后种植率、生化妊娠率、临床妊娠率及早期流产率均无显著差异
- 作者推荐女性在IVF治疗前接种COVID-19疫苗
核心结论
- 卵巢刺激前接种灭活COVID-19疫苗对IVF结局(包括卵巢刺激结局、胚胎发育和妊娠率)几乎没有影响
- 作者认为接种对IVF结局无不利影响,推荐女性在进行IVF治疗前接种COVID-19疫苗
研究设计与样本
- 回顾性队列研究,在广州医科大学附属第三医院进行
- 暴露组为240例卵巢刺激前接种CoronaVac或国药COVID-19疫苗的女性,非暴露组为1343例卵巢刺激前未接种的女性
- 所有参与者于2021年3月1日至2021年9月15日期间接受新鲜胚胎移植,随访至妊娠12周
- 采用回归分析控制胚胎发育和妊娠率的混杂因素,并采用倾向性评分匹配(PSM)平衡两组基线参数
- 主要结局为持续妊娠率
主要发现
- 线性回归分析显示,调整混杂因素后,获卵数(回归系数B=-0.299,P=0.264)、可移植胚胎数(B=-0.203,P=0.127)和囊胚数(B=-0.250,P=0.105)与卵巢刺激前接种状态无关
- 接种组持续妊娠率36.3% vs 未接种组40.7%(P=0.199),调整后比值比(OR)=0.91,95%CI=0.68-1.22,P=0.52
- PSM后,接种组 vs 未接种组的持续妊娠率36.0% vs 39.9%(P=0.272)、种植率35.4% vs 38.3%(P=0.325)、生化妊娠率47.3% vs 51.6%(P=0.232)、临床妊娠率44.4% vs 47.4%(P=0.398)和早期流产率15.0% vs 12.1%(P=0.399)均无显著差异
临床怎么用
- 作者认为接种对IVF结局无不利影响,推荐女性在进行IVF治疗前接种COVID-19疫苗
局限性
- 这是一项针对不孕女性的回顾性研究
- 本研究结果需要更大队列的前瞻性研究来确认
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do inactivated coronavirus disease-2019 (COVID-19) vaccines affect IVF outcomes among the vaccine recipients? SUMMARY ANSWER: The receipt of inactivated COVID-19 vaccines before ovarian stimulation has little effect on the outcomes of IVF, including ovarian stimulation outcomes, embryo development and pregnancy rates. WHAT IS KNOWN ALREADY: Limited studies have reported that COVID-19 vaccines do not affect ovarian function, embryo development or pregnancy outcomes. STUDY DESIGN, SIZE, DURATION: This was a retrospective cohort study performed at the Third Affiliated Hospital of Guangzhou Medical University on 240 women vaccinated with either CoronaVac or Sinopharm COVID-19 before ovarian stimulation in the exposed group and 1343 unvaccinated women before ovarian stimulation in the unexposed group. All participants received fresh embryo transfers between 1 March 2021 and 15 September 2021. The included women were followed up until 12 weeks of gestation. PARTICIPANTS/MATERIALS, SETTING, METHODS: Vaccination information of all subjects was followed up by a nurse, and the IVF data were obtained from the IVF data system. The following aspects were compared between the vaccinated and the unvaccinated groups: parameters of ovarian stimulation, embryo development and pregnancy rates. Regression analyses were performed to control for confounders of embryo development and pregnancy rates. Propensity score matching (PSM) was performed to balance the baseline parameters of the two groups. The primary outcome was the ongoing pregnancy rate. MAIN RESULTS AND THE ROLE OF CHANCE: Liner regression analysis revealed that the number of oocytes retrieved (regression coefficient (B) = -0.299, P = 0.264), embryos suitable for transfer (B = -0.203, P = 0.127) and blastocysts (B = -0.250, P = 0.105) were not associated with the status of vaccination before ovarian stimulation, after adjusting for the confounders. The ongoing pregnancy rate in the women of the vaccinated group was not significantly lower than that in the unvaccinated group (36.3% vs 40.7%, P = 0.199) (adjust odd ratio = 0.91, 95% CI = 0.68-1.22, P = 0.52). After PSM, the rates of ongoing pregnancy (36.0% vs 39.9%, P = 0.272), implantation (35.4% vs 38.3%, P = 0.325), biochemical pregnancy (47.3% vs 51.6%, P = 0.232), clinical pregnancy (44.4% vs 47.4%, P = 0.398) and early miscarriage (15.0% vs 12.1%, P = 0.399) were not significantly different between the vaccinated and the unvaccinated groups. LIMITATIONS, REASONS FOR CAUTION: This is a retrospective study of women with infertility. The results from the present study warrant confirmation by prospective studies with a larger cohort. WIDER IMPLICATIONS OF THE FINDINGS: This is the first study with a large sample size on the effect of inactivated COVID-19 vaccines on ongoing pregnancy rates of women undergoing IVF. The present results showed that vaccination has no detrimental effect on IVF outcomes. Therefore, women are recommended to receive COVID-19 vaccines before undergoing their IVF treatment. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the National Key Research and Development Program of China (No. 2018YFC1003803 to J.L.), the Guangzhou Science and Technology Plan Project (No. 202102010076 to H.L.) and the Medical Key Discipline of Guangzhou (2021-2023), as well as the Sino-German Center for Research Promotion Rapid Response Funding Call for Bilateral Collaborative Proposals between China and Germany in COVID-19 Related Research (No. C-0032 to Xingfei Pan). The authors declare no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Wu Y, Cao M, Lin Y, et al. Inactivated COVID-19 vaccination does not affect in vitro fertilization outcomes in women. Hum Reprod. 2022. PMID: 35876815. doi:10.1093/humrep/deac160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。